3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium

C144H204B3Br3I3N28O14V- — CID 159081845

About 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium

3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium (PubChem CID 159081845) has the molecular formula C144H204B3Br3I3N28O14V- and a molecular weight of 3255.20 g/mol. Its IUPAC name is 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium.

Molecular Properties

• Compound Name: 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium
• PubChem CID: 159081845
• Molecular Formula: C144H204B3Br3I3N28O14V-
• Molecular Weight: 3255.20 g/mol
• Exact Mass: 3251.05
• IUPAC Name: 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium
• SMILES: C.C.C.C.C.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1CCN(Cc2cncc(-c3ccc4[nH]nc(C(=O)Nc5cnccn5)c4c3)c2)CC1.CC1CCN(Cc2cncc(-c3ccc4c(c3)c(C(=O)Nc3cnccn3)nn4C3CCCCO3)c2)CC1.CC1CCN(Cc2cncc(B3OC(C)(C)C(C)(C)O3)c2)CC1.CC1CCN(Cc2cncc(Br)c2)CC1.CCC.CCC(I)(I)I.C[C-](C)C.Nc1cnccn1.O=C(Nc1cnccn1)c1nn(C2CCCCO2)c2ccc(Br)cc12.O=C(O)c1nn(C2CCCCO2)c2ccc(Br)cc12.[V]
• InChI: InChI=1S/C29H33N7O2.C24H25N7O.C18H29BN2O2.C17H16BrN5O2.C13H13BrN2O3.C12H24B2O4.C12H17BrN2.C4H5N3.C4H9.C3H5I3.C3H8.5CH4.V/c1-20-7-11-35(12-8-20)19-21-14-23(17-31-16-21)22-5-6-25-24(15-22)28(29(37)33-26-18-30-9-10-32-26)34-36(25)27-4-2-3-13-38-27;1-16-4-8-31(9-5-16)15-17-10-19(13-26-12-17)18-2-3-21-20(11-18)23(30-29-21)24(32)28-22-14-25-6-7-27-22;1-14-6-8-21(9-7-14)13-15-10-16(12-20-11-15)19-22-17(2,3)18(4,5)23-19;18-11-4-5-13-12(9-11)16(17(24)21-14-10-19-6-7-20-14)22-23(13)15-3-1-2-8-25-15;14-8-4-5-10-9(7-8)12(13(17)18)15-16(10)11-3-1-2-6-19-11;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-10-2-4-15(5-3-10)9-11-6-12(13)8-14-7-11;5-4-3-6-1-2-7-4;1-4(2)3;1-2-3(4,5)6;1-3-2;;;;;;/h5-6,9-10,14-18,20,27H,2-4,7-8,11-13,19H2,1H3,(H,32,33,37);2-3,6-7,10-14,16H,4-5,8-9,15H2,1H3,(H,29,30)(H,27,28,32);10-12,14H,6-9,13H2,1-5H3;4-7,9-10,15H,1-3,8H2,(H,20,21,24);4-5,7,11H,1-3,6H2,(H,17,18);1-8H3;6-8,10H,2-5,9H2,1H3;1-3H,(H2,5,7);1-3H3;2H2,1H3;3H2,1-2H3;5*1H4;/q;;;;;;;;-1
• InChIKey: HHDLSWYZWAOYGD-UHFFFAOYSA-N
• XLogP: 33.27
• TPSA: 483.47 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 37
• Rotatable Bonds: 23
• Heavy Atoms: 196
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3255.20
LogP ≤ 5	33.27
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium?

The IUPAC name of 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium (CID 159081845) is 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium.

What is the SMILES notation for 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium?

The canonical SMILES for 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium is C.C.C.C.C.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1CCN(Cc2cncc(-c3ccc4[nH]nc(C(=O)Nc5cnccn5)c4c3)c2)CC1.CC1CCN(Cc2cncc(-c3ccc4c(c3)c(C(=O)Nc3cnccn3)nn4C3CCCCO3)c2)CC1.CC1CCN(Cc2cncc(B3OC(C)(C)C(C)(C)O3)c2)CC1.CC1CCN(Cc2cncc(Br)c2)CC1.CCC.CCC(I)(I)I.C[C-](C)C.Nc1cnccn1.O=C(Nc1cnccn1)c1nn(C2CCCCO2)c2ccc(Br)cc12.O=C(O)c1nn(C2CCCCO2)c2ccc(Br)cc12.[V].

What is the InChIKey of 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium?

The InChIKey is HHDLSWYZWAOYGD-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H33N7O2.C24H25N7O.C18H29BN2O2.C17H16BrN5O2.C13H13BrN2O3.C12H24B2O4.C12H17BrN2.C4H5N3.C4H9.C3H5I3.C3H8.5CH4.V/c1-20-7-11-35(12-8-20)19-21-14-23(17-31-16-21)22-5-6-25-24(15-22)28(29(37)33-26-18-30-9-10-32-26)34-36(25)27-4-2-3-13-38-27;1-16-4-8-31(9-5-16)15-17-10-19(13-26-12-17)18-2-3-21-20(11-18)23(30-29-21)24(32)28-22-14-25-6-7-27-22;1-14-6-8-21(9-7-14)13-15-10-16(12-20-11-15)19-22-17(2,3)18(4,5)23-19;18-11-4-5-13-12(9-11)16(17(24)21-14-10-19-6-7-20-14)22-23(13)15-3-1-2-8-25-15;14-8-4-5-10-9(7-8)12(13(17)18)15-16(10)11-3-1-2-6-19-11;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-10-2-4-15(5-3-10)9-11-6-12(13)8-14-7-11;5-4-3-6-1-2-7-4;1-4(2)3;1-2-3(4,5)6;1-3-2;;;;;;/h5-6,9-10,14-18,20,27H,2-4,7-8,11-13,19H2,1H3,(H,32,33,37);2-3,6-7,10-14,16H,4-5,8-9,15H2,1H3,(H,29,30)(H,27,28,32);10-12,14H,6-9,13H2,1-5H3;4-7,9-10,15H,1-3,8H2,(H,20,21,24);4-5,7,11H,1-3,6H2,(H,17,18);1-8H3;6-8,10H,2-5,9H2,1H3;1-3H,(H2,5,7);1-3H3;2H2,1H3;3H2,1-2H3;5*1H4;/q;;;;;;;;-1;;;;;;;;.

What are the key properties of 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium?

3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium has a molecular weight of 3255.20 g/mol, XLogP of 33.27, 23 rotatable bonds, 6 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 3-bromo-5-[(4-methylpiperidin-1-yl)methyl]pyridine;5-bromo-1-(oxan-2-yl)indazole-3-carboxylic acid;5-bromo-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;methane;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-1-(oxan-2-yl)-N-pyrazin-2-ylindazole-3-carboxamide;5-[5-[(4-methylpiperidin-1-yl)methyl]-3-pyridinyl]-N-pyrazin-2-yl-1H-indazole-3-carboxamide;3-[(4-methylpiperidin-1-yl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;2-methylpropane;propane;pyrazin-2-amine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;1,1,1-triiodopropane;vanadium is sourced from PubChem (CID 159081845), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).